National Institute for Public Health and the Environment (RIVM) Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01708720
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

ipv (2 trials)

live oral poliovirus type 1, 2 and 3 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Poliomyelitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2